InspiroGene™ is McKesson’s main center for CGT commercialization. It serves as the front door for McKesson’s cell and gene offerings, providing a single point of contact for biopharma partners. Through this model, Biologics by McKesson provides specialty pharmacy services and patient hub programs built for complex therapies. We also work with McKesson’s logistics and distribution partners to deliver full-service CGT solutions from end to end.

Our CGT services are personalized for every biopharma partner, treatment site, therapy and patient. These treatment journeys may involve one-time therapies or ongoing care, delivered at qualified treatment centers (QTCs) — specialized sites authorized to administer CGTs — or outpatient clinics. Our programs support CGT market access, scalability, and visibility across every patient’s treatment path. They also blend operational precision with real-world flexibility.